{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29073181", "DateCompleted": {"Year": "2017", "Month": "12", "Day": "11"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "10", "Day": "26"}], "Language": ["eng"], "ELocationID": ["e0186864", "10.1371/journal.pone.0186864"], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "12", "Issue": "10", "PubDate": {"Year": "2017"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "Modulation of T-type Ca2+ channels by Lavender and Rosemary extracts.", "Pagination": {"StartPage": "e0186864", "MedlinePgn": "e0186864"}, "Abstract": {"AbstractText": ["Medicinal plants represent a significant reservoir of unexplored substances for early-stage drug discovery. Of interest, two flowering Mediterranean plants have been used for thousands of years for their beneficial effects on nervous disorders, including anxiety and mood. However, the therapeutic potential of these plants regarding their ability to target ion channels and neuronal excitability remains largely unknown. Towards this goal, we have investigated the ability of Lavender and Rosemary to modulate T-type calcium channels (TTCCs). TTCCs play important roles in neuronal excitability, neuroprotection, sensory processes and sleep. These channels are also involved in epilepsy and pain. Using the whole-cell patch-clamp technique, we have characterized how Lavender and Rosemary extracts, as well as their major active compounds Linalool and Rosmarinic acid, modulate the electrophysiological properties of recombinant TTCCs (CaV3.2) expressed in HEK-293T cells. Both the methanolic and essential oil extracts as well as the active compounds of these plants inhibit Cav3.2 current in a concentration-dependent manner. In addition, these products also induce a negative shift of the steady-state inactivation of CaV3.2 current with no change in the activation properties. Taken together, our findings reveal that TTCCs are a molecular target of the Lavender and Rosemary compounds, suggesting that inhibition of TTCCs could contribute to the anxiolytic and the neuroprotective effects of these plants."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institut de G\u00e9nomique Fonctionnelle, CNRS, INSERM, University of Montpellier, Montpellier, France."}, {"Identifier": [], "Affiliation": "LabEx 'Ion Channel Science and Therapeutics', Montpellier, France."}, {"Identifier": [], "Affiliation": "Laboratoire de Neurosciences, Physiopathologies Int\u00e9gr\u00e9es et Substances Naturelles, Facult\u00e9 des Sciences et Techniques Mohammedia, Universit\u00e9 Hassan II, Casablanca, Morocco."}], "LastName": "El Alaoui", "ForeName": "Chaymae", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institut de G\u00e9nomique Fonctionnelle, CNRS, INSERM, University of Montpellier, Montpellier, France."}, {"Identifier": [], "Affiliation": "LabEx 'Ion Channel Science and Therapeutics', Montpellier, France."}], "LastName": "Chemin", "ForeName": "Jean", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratoire de Neurosciences, Physiopathologies Int\u00e9gr\u00e9es et Substances Naturelles, Facult\u00e9 des Sciences et Techniques Mohammedia, Universit\u00e9 Hassan II, Casablanca, Morocco."}], "LastName": "Fechtali", "ForeName": "Taoufiq", "Initials": "T"}, {"Identifier": ["0000-0002-1638-7604"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institut de G\u00e9nomique Fonctionnelle, CNRS, INSERM, University of Montpellier, Montpellier, France."}, {"Identifier": [], "Affiliation": "LabEx 'Ion Channel Science and Therapeutics', Montpellier, France."}], "LastName": "Lory", "ForeName": "Philippe", "Initials": "P"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Calcium Channel Blockers"}, {"RegistryNumber": "0", "NameOfSubstance": "Calcium Channels, T-Type"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "Y4S76JWI15", "NameOfSubstance": "Methanol"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Calcium Channel Blockers"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Calcium Channels, T-Type"}, {"QualifierName": [], "DescriptorName": "HEK293 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Lavandula"}, {"QualifierName": ["chemistry"], "DescriptorName": "Methanol"}, {"QualifierName": ["drug effects"], "DescriptorName": "Neurons"}, {"QualifierName": [], "DescriptorName": "Patch-Clamp Techniques"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Rosmarinus"}], "CoiStatement": "<b>Competing Interests: </b>The authors have declared that no competing interests exist."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Petrovska BB. Historical review of medicinal plants' usage. Pharmacogn Rev. 2012;6(11):1\u20135. doi: 10.4103/0973-7847.95849 ; PubMed Central PMCID: PMCPMC3358962.", "ArticleIdList": ["10.4103/0973-7847.95849", "PMC3358962", "22654398"]}, {"Citation": "Sen T, Samanta SK. Medicinal plants, human health and biodiversity: a broad review. Adv Biochem Eng Biotechnol. 2015;147:59\u2013110. doi: 10.1007/10_2014_273 .", "ArticleIdList": ["10.1007/10_2014_273", "25001990"]}, {"Citation": "Sucher NJ, Carles MC. A pharmacological basis of herbal medicines for epilepsy. Epilepsy Behav. 2015;52(Pt B):308\u201318. doi: 10.1016/j.yebeh.2015.05.012 .", "ArticleIdList": ["10.1016/j.yebeh.2015.05.012", "26074183"]}, {"Citation": "Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 2005;4(3):206\u201320. doi: 10.1038/nrd1657 .", "ArticleIdList": ["10.1038/nrd1657", "15729362"]}, {"Citation": "Woronuk G, Demissie Z, Rheault M, Mahmoud S. Biosynthesis and therapeutic properties of Lavandula essential oil constituents. Planta Med. 2011;77(1):7\u201315. doi: 10.1055/s-0030-1250136 .", "ArticleIdList": ["10.1055/s-0030-1250136", "20665367"]}, {"Citation": "Koulivand PH, Khaleghi Ghadiri M, Gorji A. Lavender and the nervous system. Evid Based Complement Alternat Med. 2013;2013:681304\ndoi: 10.1155/2013/681304 ; PubMed Central PMCID: PMCPMC3612440.", "ArticleIdList": ["10.1155/2013/681304", "PMC3612440", "23573142"]}, {"Citation": "Ngo SN, Williams DB, Head RJ. Rosemary and cancer prevention: preclinical perspectives. Crit Rev Food Sci Nutr. 2011;51(10):946\u201354. doi: 10.1080/10408398.2010.490883 .", "ArticleIdList": ["10.1080/10408398.2010.490883", "21955093"]}, {"Citation": "Cavanagh HM, Wilkinson JM. Biological activities of lavender essential oil. Phytother Res. 2002;16(4):301\u20138. doi: 10.1002/ptr.1103 .", "ArticleIdList": ["10.1002/ptr.1103", "12112282"]}, {"Citation": "Gilani AH, Aziz N, Khan MA, Shaheen F, Jabeen Q, Siddiqui BS, et al. Ethnopharmacological evaluation of the anticonvulsant, sedative and antispasmodic activities of Lavandula stoechas L. J Ethnopharmacol. 2000;71(1\u20132):161\u20137. .", "ArticleIdList": ["10904159"]}, {"Citation": "Schuwald AM, Noldner M, Wilmes T, Klugbauer N, Leuner K, Muller WE. Lavender oil-potent anxiolytic properties via modulating voltage dependent calcium channels. PLoS One. 2013;8(4):e59998\ndoi: 10.1371/journal.pone.0059998 ; PubMed Central PMCID: PMCPMC3639265.", "ArticleIdList": ["10.1371/journal.pone.0059998", "PMC3639265", "23637742"]}, {"Citation": "Lehrner J, Marwinski G, Lehr S, Johren P, Deecke L. Ambient odors of orange and lavender reduce anxiety and improve mood in a dental office. Physiol Behav. 2005;86(1\u20132):92\u20135. doi: 10.1016/j.physbeh.2005.06.031 .", "ArticleIdList": ["10.1016/j.physbeh.2005.06.031", "16095639"]}, {"Citation": "Herrero M, Plaza M, Cifuentes A, Ibanez E. Green processes for the extraction of bioactives from Rosemary: Chemical and functional characterization via ultra-performance liquid chromatography-tandem mass spectrometry and in-vitro assays. J Chromatogr A. 2010;1217(16):2512\u201320. doi: 10.1016/j.chroma.2009.11.032 .", "ArticleIdList": ["10.1016/j.chroma.2009.11.032", "19945706"]}, {"Citation": "Xiao C, Dai H, Liu H, Wang Y, Tang H. Revealing the metabonomic variation of rosemary extracts using 1H NMR spectroscopy and multivariate data analysis. J Agric Food Chem. 2008;56(21):10142\u201353. doi: 10.1021/jf8016833 .", "ArticleIdList": ["10.1021/jf8016833", "18800806"]}, {"Citation": "Gonzalez-Trujano ME, Pena EI, Martinez AL, Moreno J, Guevara-Fefer P, Deciga-Campos M, et al.\nEvaluation of the antinociceptive effect of Rosmarinus officinalis L. using three different experimental models in rodents. J Ethnopharmacol. 2007;111(3):476\u201382. doi: 10.1016/j.jep.2006.12.011 .", "ArticleIdList": ["10.1016/j.jep.2006.12.011", "17223299"]}, {"Citation": "Takaki I, Bersani-Amado LE, Vendruscolo A, Sartoretto SM, Diniz SP, Bersani-Amado CA, et al.\nAnti-inflammatory and antinociceptive effects of Rosmarinus officinalis L. essential oil in experimental animal models. J Med Food. 2008;11(4):741\u20136. doi: 10.1089/jmf.2007.0524 .", "ArticleIdList": ["10.1089/jmf.2007.0524", "19053868"]}, {"Citation": "Park SE, Kim S, Sapkota K, Kim SJ. Neuroprotective effect of Rosmarinus officinalis extract on human dopaminergic cell line, SH-SY5Y. Cell Mol Neurobiol. 2010;30(5):759\u201367. doi: 10.1007/s10571-010-9502-3 .", "ArticleIdList": ["10.1007/s10571-010-9502-3", "20563702"]}, {"Citation": "Ozarowski M, Mikolajczak PL, Bogacz A, Gryszczynska A, Kujawska M, Jodynis-Liebert J, et al.\nRosmarinus officinalis L. leaf extract improves memory impairment and affects acetylcholinesterase and butyrylcholinesterase activities in rat brain. Fitoterapia. 2013;91:261\u201371. doi: 10.1016/j.fitote.2013.09.012 .", "ArticleIdList": ["10.1016/j.fitote.2013.09.012", "24080468"]}, {"Citation": "Rocha J, Eduardo-Figueira M, Barateiro A, Fernandes A, Brites D, Bronze R, et al.\nAnti-inflammatory effect of rosmarinic acid and an extract of Rosmarinus officinalis in rat models of local and systemic inflammation. Basic Clin Pharmacol Toxicol. 2015;116(5):398\u2013413. doi: 10.1111/bcpt.12335 .", "ArticleIdList": ["10.1111/bcpt.12335", "25287116"]}, {"Citation": "Gamaro GD, Suyenaga E, Borsoi M, Lermen J, Pereira P, Ardenghi P. Effect of rosmarinic and caffeic acids on inflammatory and nociception process in rats. ISRN Pharmacol. 2011;2011:451682\ndoi: 10.5402/2011/451682 ; PubMed Central PMCID: PMCPMC3197075.", "ArticleIdList": ["10.5402/2011/451682", "PMC3197075", "22084714"]}, {"Citation": "Jin X, Liu P, Yang F, Zhang YH, Miao D. Rosmarinic acid ameliorates depressive-like behaviors in a rat model of CUS and Up-regulates BDNF levels in the hippocampus and hippocampal-derived astrocytes. Neurochem Res. 2013;38(9):1828\u201337. doi: 10.1007/s11064-013-1088-y .", "ArticleIdList": ["10.1007/s11064-013-1088-y", "23756732"]}, {"Citation": "Huang L, Abuhamdah S, Howes MJ, Dixon CL, Elliot MS, Ballard C, et al.\nPharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti-agitation properties: focus on ligand-gated channels. J Pharm Pharmacol. 2008;60(11):1515\u201322. doi: 10.1211/jpp/60.11.0013 .", "ArticleIdList": ["10.1211/jpp/60.11.0013", "18957173"]}, {"Citation": "Chioca LR, Ferro MM, Baretta IP, Oliveira SM, Silva CR, Ferreira J, et al.\nAnxiolytic-like effect of lavender essential oil inhalation in mice: participation of serotonergic but not GABAA/benzodiazepine neurotransmission. J Ethnopharmacol. 2013;147(2):412\u20138. doi: 10.1016/j.jep.2013.03.028 .", "ArticleIdList": ["10.1016/j.jep.2013.03.028", "23524167"]}, {"Citation": "Perez-Reyes E. Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev. 2003;83(1):117\u201361. doi: 10.1152/physrev.00018.2002 .", "ArticleIdList": ["10.1152/physrev.00018.2002", "12506128"]}, {"Citation": "Llinas RR, Steriade M. Bursting of thalamic neurons and states of vigilance. J Neurophysiol. 2006;95(6):3297\u2013308. doi: 10.1152/jn.00166.2006 .", "ArticleIdList": ["10.1152/jn.00166.2006", "16554502"]}, {"Citation": "Catterall WA, Goldin AL, Waxman SG. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev. 2005;57(4):397\u2013409. doi: 10.1124/pr.57.4.4 .", "ArticleIdList": ["10.1124/pr.57.4.4", "16382098"]}, {"Citation": "Talley EM, Cribbs LL, Lee JH, Daud A, Perez-Reyes E, Bayliss DA. Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels. J Neurosci. 1999;19(6):1895\u2013911. .", "ArticleIdList": ["PMC6782581", "10066243"]}, {"Citation": "Anderson MP, Mochizuki T, Xie J, Fischler W, Manger JP, Talley EM, et al.\nThalamic Cav3.1 T-type Ca2+ channel plays a crucial role in stabilizing sleep. Proc Natl Acad Sci U S A. 2005;102(5):1743\u20138. doi: 10.1073/pnas.0409644102 ; PubMed Central PMCID: PMCPMC547889.", "ArticleIdList": ["10.1073/pnas.0409644102", "PMC547889", "15677322"]}, {"Citation": "Chemin J, Monteil A, Briquaire C, Richard S, Perez-Reyes E, Nargeot J, et al. Overexpression of T-type calcium channels in HEK-293 cells increases intracellular calcium without affecting cellular proliferation. FEBS letters. 2000;478(1\u20132):166\u201372. .", "ArticleIdList": ["10922490"]}, {"Citation": "Chemin J, Nargeot J, Lory P. Neuronal T-type alpha 1H calcium channels induce neuritogenesis and expression of high-voltage-activated calcium channels in the NG108-15 cell line. J Neurosci. 2002;22(16):6856\u201362. .", "ArticleIdList": ["PMC6757877", "12177183"]}, {"Citation": "Chemin J, Monteil A, Perez-Reyes E, Bourinet E, Nargeot J, Lory P. Specific contribution of human T-type calcium channel isotypes (alpha(1G), alpha(1H) and alpha(1I)) to neuronal excitability. J Physiol. 2002;540(Pt 1):3\u201314. doi: 10.1113/jphysiol.2001.013269 ; PubMed Central PMCID: PMCPMC2290209.", "ArticleIdList": ["10.1113/jphysiol.2001.013269", "PMC2290209", "11927664"]}, {"Citation": "Cain SM, Snutch TP. T-type calcium channels in burst-firing, network synchrony, and epilepsy. Biochim Biophys Acta. 2013;1828(7):1572\u20138. doi: 10.1016/j.bbamem.2012.07.028 .", "ArticleIdList": ["10.1016/j.bbamem.2012.07.028", "22885138"]}, {"Citation": "Bourinet E, Alloui A, Monteil A, Barrere C, Couette B, Poirot O, et al.\nSilencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. The EMBO journal. 2005;24(2):315\u201324. doi: 10.1038/sj.emboj.7600515 ; PubMed Central PMCID: PMCPMC545807.", "ArticleIdList": ["10.1038/sj.emboj.7600515", "PMC545807", "15616581"]}, {"Citation": "Todorovic SM, Jevtovic-Todorovic V. T-type voltage-gated calcium channels as targets for the development of novel pain therapies. Br J Pharmacol. 2011;163(3):484\u201395. doi: 10.1111/j.1476-5381.2011.01256.x ; PubMed Central PMCID: PMCPMC3101611.", "ArticleIdList": ["10.1111/j.1476-5381.2011.01256.x", "PMC3101611", "21306582"]}, {"Citation": "Chemin J, Monteil A, Perez-Reyes E, Nargeot J, Lory P. Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. The EMBO journal. 2001;20(24):7033\u201340. doi: 10.1093/emboj/20.24.7033 ; PubMed Central PMCID: PMCPMC125779.", "ArticleIdList": ["10.1093/emboj/20.24.7033", "PMC125779", "11742980"]}, {"Citation": "Barbara G, Alloui A, Nargeot J, Lory P, Eschalier A, Bourinet E, et al.\nT-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids. J Neurosci. 2009;29(42):13106\u201314. doi: 10.1523/JNEUROSCI.2919-09.2009 .", "ArticleIdList": ["10.1523/JNEUROSCI.2919-09.2009", "PMC6665211", "19846698"]}, {"Citation": "Cazade M, Nuss CE, Bidaud I, Renger JJ, Uebele VN, Lory P, et al.\nCross-modulation and molecular interaction at the Cav3.3 protein between the endogenous lipids and the T-type calcium channel antagonist TTA-A2. Mol Pharmacol. 2014;85(2):218\u201325. doi: 10.1124/mol.113.089581 .", "ArticleIdList": ["10.1124/mol.113.089581", "24214826"]}, {"Citation": "Chuang RS, Jaffe H, Cribbs L, Perez-Reyes E, Swartz KJ. Inhibition of T-type voltage-gated calcium channels by a new scorpion toxin. Nat Neurosci. 1998;1(8):668\u201374. doi: 10.1038/3669 .", "ArticleIdList": ["10.1038/3669", "10196582"]}, {"Citation": "Seo H, Li HY, Perez-Reyes E, Lee JH. Effects of eugenol on T-type Ca2+ channel isoforms. J Pharmacol Exp Ther. 2013;347(2):310\u20137. doi: 10.1124/jpet.113.207936 .", "ArticleIdList": ["10.1124/jpet.113.207936", "24014106"]}, {"Citation": "Ross HR, Napier I, Connor M. Inhibition of recombinant human T-type calcium channels by Delta9-tetrahydrocannabinol and cannabidiol. J Biol Chem. 2008;283(23):16124\u201334. doi: 10.1074/jbc.M707104200 ; PubMed Central PMCID: PMCPMC3259625.", "ArticleIdList": ["10.1074/jbc.M707104200", "PMC3259625", "18390906"]}, {"Citation": "Enyeart JA, Liu H, Enyeart JJ. Curcumin inhibits ACTH- and angiotensin II-stimulated cortisol secretion and Ca(v)3.2 current. J Nat Prod. 2009;72(8):1533\u20137. doi: 10.1021/np900227x ; PubMed Central PMCID: PMCPMC2853174.", "ArticleIdList": ["10.1021/np900227x", "PMC2853174", "19653644"]}, {"Citation": "Traboulsie A, Chemin J, Kupfer E, Nargeot J, Lory P. T-type calcium channels are inhibited by fluoxetine and its metabolite norfluoxetine. Mol Pharmacol. 2006;69(6):1963\u20138. doi: 10.1124/mol.105.020842 .", "ArticleIdList": ["10.1124/mol.105.020842", "16510561"]}, {"Citation": "Martin RL, Lee JH, Cribbs LL, Perez-Reyes E, Hanck DA. Mibefradil block of cloned T-type calcium channels. J Pharmacol Exp Ther. 2000;295(1):302\u20138. .", "ArticleIdList": ["10991994"]}, {"Citation": "Zamponi GW, Striessnig J, Koschak A, Dolphin AC. The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential. Pharmacol Rev. 2015;67(4):821\u201370. doi: 10.1124/pr.114.009654 ; PubMed Central PMCID: PMCPMC4630564.", "ArticleIdList": ["10.1124/pr.114.009654", "PMC4630564", "26362469"]}, {"Citation": "Narusuye K, Kawai F, Matsuzaki K, Miyachi E. Linalool suppresses voltage-gated currents in sensory neurons and cerebellar Purkinje cells. J Neural Transm (Vienna). 2005;112(2):193\u2013203. doi: 10.1007/s00702-004-0187-y .", "ArticleIdList": ["10.1007/s00702-004-0187-y", "15365786"]}, {"Citation": "Elisabetsky E, Brum LF, Souza DO. Anticonvulsant properties of linalool in glutamate-related seizure models. Phytomedicine. 1999;6(2):107\u201313. .", "ArticleIdList": ["10374249"]}, {"Citation": "Re L, Barocci S, Sonnino S, Mencarelli A, Vivani C, Paolucci G, et al.\nLinalool modifies the nicotinic receptor-ion channel kinetics at the mouse neuromuscular junction. Pharmacol Res. 2000;42(2):177\u201382. doi: 10.1006/phrs.2000.0671 .", "ArticleIdList": ["10.1006/phrs.2000.0671", "10887049"]}, {"Citation": "Linck VM, da Silva AL, Figueiro M, Piato AL, Herrmann AP, Dupont Birck F, et al.\nInhaled linalool-induced sedation in mice. Phytomedicine. 2009;16(4):303\u20137. doi: 10.1016/j.phymed.2008.08.001 .", "ArticleIdList": ["10.1016/j.phymed.2008.08.001", "18824339"]}, {"Citation": "Linck VM, da Silva AL, Figueiro M, Caramao EB, Moreno PR, Elisabetsky E. Effects of inhaled Linalool in anxiety, social interaction and aggressive behavior in mice. Phytomedicine. 2010;17(8\u20139):679\u201383. doi: 10.1016/j.phymed.2009.10.002 .", "ArticleIdList": ["10.1016/j.phymed.2009.10.002", "19962290"]}, {"Citation": "Kawai F, Kurahashi T, Kaneko A. T-type Ca2+ channel lowers the threshold of spike generation in the newt olfactory receptor cell. J Gen Physiol. 1996;108(6):525\u201335. ; PubMed Central PMCID: PMCPMC2229340.", "ArticleIdList": ["PMC2229340", "8972390"]}, {"Citation": "Fallarini S, Miglio G, Paoletti T, Minassi A, Amoruso A, Bardelli C, et al.\nClovamide and rosmarinic acid induce neuroprotective effects in in vitro models of neuronal death. Br J Pharmacol. 2009;157(6):1072\u201384. doi: 10.1111/j.1476-5381.2009.00213.x ; PubMed Central PMCID: PMCPMC2737666.", "ArticleIdList": ["10.1111/j.1476-5381.2009.00213.x", "PMC2737666", "19466982"]}, {"Citation": "Kimura Y, Okuda H, Okuda T, Hatano T, Arichi S. Studies on the activities of tannins and related compounds, X. Effects of caffeetannins and related compounds on arachidonate metabolism in human polymorphonuclear leukocytes. J Nat Prod. 1987;50(3):392\u20139. .", "ArticleIdList": ["2822857"]}, {"Citation": "Kelm MA, Nair MG, Strasburg GM, DeWitt DL. Antioxidant and cyclooxygenase inhibitory phenolic compounds from Ocimum sanctum Linn. Phytomedicine. 2000;7(1):7\u201313. doi: 10.1016/S0944-7113(00)80015-X .", "ArticleIdList": ["10.1016/S0944-7113(00)80015-X", "10782484"]}, {"Citation": "Sahu A, Rawal N, Pangburn MK. Inhibition of complement by covalent attachment of rosmarinic acid to activated C3b. Biochem Pharmacol. 1999;57(12):1439\u201346. .", "ArticleIdList": ["10353266"]}, {"Citation": "Won J, Hur YG, Hur EM, Park SH, Kang MA, Choi Y, et al.\nRosmarinic acid inhibits TCR-induced T cell activation and proliferation in an Lck-dependent manner. Eur J Immunol. 2003;33(4):870\u20139. doi: 10.1002/eji.200323010 .", "ArticleIdList": ["10.1002/eji.200323010", "12672052"]}, {"Citation": "Huguenard JR. Low-threshold calcium currents in central nervous system neurons. Annu Rev Physiol. 1996;58:329\u201348. doi: 10.1146/annurev.ph.58.030196.001553 .", "ArticleIdList": ["10.1146/annurev.ph.58.030196.001553", "8815798"]}, {"Citation": "Hondeghem LM, Katzung BG. Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs. Annu Rev Pharmacol Toxicol. 1984;24:387\u2013423. doi: 10.1146/annurev.pa.24.040184.002131 .", "ArticleIdList": ["10.1146/annurev.pa.24.040184.002131", "6203481"]}, {"Citation": "Hering S, Aczel S, Kraus RL, Berjukow S, Striessnig J, Timin EN. Molecular mechanism of use-dependent calcium channel block by phenylalkylamines: role of inactivation. Proc Natl Acad Sci U S A. 1997;94(24):13323\u20138. ; PubMed Central PMCID: PMCPMC24307.", "ArticleIdList": ["PMC24307", "9371844"]}, {"Citation": "Gonzalez-Rodriguez P, Falcon D, Castro MJ, Urena J, Lopez-Barneo J, Castellano A. Hypoxic induction of T-type Ca(2+) channels in rat cardiac myocytes: role of HIF-1alpha and RhoA/ROCK signalling. J Physiol. 2015;593(21):4729\u201345. doi: 10.1113/JP271053 ; PubMed Central PMCID: PMCPMC4626545.", "ArticleIdList": ["10.1113/JP271053", "PMC4626545", "26331302"]}, {"Citation": "Carabelli V, Marcantoni A, Comunanza V, de Luca A, Diaz J, Borges R, et al.\nChronic hypoxia up-regulates alpha1H T-type channels and low-threshold catecholamine secretion in rat chromaffin cells. J Physiol. 2007;584(Pt 1):149\u201365. doi: 10.1113/jphysiol.2007.132274 ; PubMed Central PMCID: PMCPMC2277059.", "ArticleIdList": ["10.1113/jphysiol.2007.132274", "PMC2277059", "17690152"]}, {"Citation": "Mariot P, Vanoverberghe K, Lalevee N, Rossier MF, Prevarskaya N. Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells. J Biol Chem. 2002;277(13):10824\u201333. doi: 10.1074/jbc.M108754200 .", "ArticleIdList": ["10.1074/jbc.M108754200", "11799114"]}, {"Citation": "Powell KL, Cain SM, Snutch TP, O'Brien TJ. Low threshold T-type calcium channels as targets for novel epilepsy treatments. Br J Clin Pharmacol. 2014;77(5):729\u201339. doi: 10.1111/bcp.12205 ; PubMed Central PMCID: PMCPMC4004393.", "ArticleIdList": ["10.1111/bcp.12205", "PMC4004393", "23834404"]}, {"Citation": "Tsakiridou E, Bertollini L, de Curtis M, Avanzini G, Pape HC. Selective increase in T-type calcium conductance of reticular thalamic neurons in a rat model of absence epilepsy. J Neurosci. 1995;15(4):3110\u20137. .", "ArticleIdList": ["PMC6577780", "7722649"]}, {"Citation": "Sakkaki S, Gangarossa G, Lerat B, Francon D, Forichon L, Chemin J, et al.\nBlockade of T-type calcium channels prevents tonic-clonic seizures in a maximal electroshock seizure model. Neuropharmacology. 2016;101:320\u20139. doi: 10.1016/j.neuropharm.2015.09.032 .", "ArticleIdList": ["10.1016/j.neuropharm.2015.09.032", "26456350"]}, {"Citation": "Lory P, Chemin J. Towards the discovery of novel T-type calcium channel blockers. Expert Opin Ther Targets. 2007;11(5):717\u201322. doi: 10.1517/14728222.11.5.717 .", "ArticleIdList": ["10.1517/14728222.11.5.717", "17465728"]}, {"Citation": "Gomora JC, Daud AN, Weiergraber M, Perez-Reyes E. Block of cloned human T-type calcium channels by succinimide antiepileptic drugs. Mol Pharmacol. 2001;60(5):1121\u201332. .", "ArticleIdList": ["11641441"]}, {"Citation": "Tringham E, Powell KL, Cain SM, Kuplast K, Mezeyova J, Weerapura M, et al.\nT-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizures. Sci Transl Med. 2012;4(121):121ra19\ndoi: 10.1126/scitranslmed.3003120 .", "ArticleIdList": ["10.1126/scitranslmed.3003120", "22344687"]}, {"Citation": "Llinas RR, Ribary U, Jeanmonod D, Kronberg E, Mitra PP. Thalamocortical dysrhythmia: A neurological and neuropsychiatric syndrome characterized by magnetoencephalography. Proc Natl Acad Sci U S A. 1999;96(26):15222\u20137. ; PubMed Central PMCID: PMCPMC24801.", "ArticleIdList": ["PMC24801", "10611366"]}, {"Citation": "Berger ND, Gadotti VM, Petrov RR, Chapman K, Diaz P, Zamponi GW. NMP-7 inhibits chronic inflammatory and neuropathic pain via block of Cav3.2 T-type calcium channels and activation of CB2 receptors. Mol Pain. 2014;10:77\ndoi: 10.1186/1744-8069-10-77 ; PubMed Central PMCID: PMCPMC4271433.", "ArticleIdList": ["10.1186/1744-8069-10-77", "PMC4271433", "25481027"]}, {"Citation": "Jagodic MM, Pathirathna S, Joksovic PM, Lee W, Nelson MT, Naik AK, et al.\nUpregulation of the T-type calcium current in small rat sensory neurons after chronic constrictive injury of the sciatic nerve. J Neurophysiol. 2008;99(6):3151\u20136. doi: 10.1152/jn.01031.2007 ; PubMed Central PMCID: PMCPMC2667888.", "ArticleIdList": ["10.1152/jn.01031.2007", "PMC2667888", "18417624"]}, {"Citation": "Huang L, Keyser BM, Tagmose TM, Hansen JB, Taylor JT, Zhuang H, et al.\nNNC 55\u20130396 [(1S,2S)-2-(2-(N-[(3-benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2, 3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium channels. J Pharmacol Exp Ther. 2004;309(1):193\u20139. doi: 10.1124/jpet.103.060814 .", "ArticleIdList": ["10.1124/jpet.103.060814", "14718587"]}, {"Citation": "Shen FY, Chen ZY, Zhong W, Ma LQ, Chen C, Yang ZJ, et al.\nAlleviation of neuropathic pain by regulating T-type calcium channels in rat anterior cingulate cortex. Mol Pain. 2015;11:7\ndoi: 10.1186/s12990-015-0008-3 ; PubMed Central PMCID: PMCPMC4357203.", "ArticleIdList": ["10.1186/s12990-015-0008-3", "PMC4357203", "25885031"]}, {"Citation": "Jarvis MF, Scott VE, McGaraughty S, Chu KL, Xu J, Niforatos W, et al.\nA peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats. Biochem Pharmacol. 2014;89(4):536\u201344. doi: 10.1016/j.bcp.2014.03.015 .", "ArticleIdList": ["10.1016/j.bcp.2014.03.015", "24726441"]}, {"Citation": "Ziegler D, Duan WR, An G, Thomas JW, Nothaft W. A randomized double-blind, placebo-, and active-controlled study of T-type calcium channel blocker ABT-639 in patients with diabetic peripheral neuropathic pain. Pain. 2015;156(10):2013\u201320. doi: 10.1097/j.pain.0000000000000263 ; PubMed Central PMCID: PMCPMC4770341.", "ArticleIdList": ["10.1097/j.pain.0000000000000263", "PMC4770341", "26067585"]}, {"Citation": "Serra J, Duan WR, Locke C, Sola R, Liu W, Nothaft W. Effects of a T-type calcium channel blocker, ABT-639, on spontaneous activity in C-nociceptors in patients with painful diabetic neuropathy: a randomized controlled trial. Pain. 2015;156(11):2175\u201383. doi: 10.1097/j.pain.0000000000000249 .", "ArticleIdList": ["10.1097/j.pain.0000000000000249", "26035253"]}, {"Citation": "Lee M. Z944: a first in class T-type calcium channel modulator for the treatment of pain. J Peripher Nerv Syst. 2014;19\nSuppl 2:S11\u20132. doi: 10.1111/jns.12080_2 .", "ArticleIdList": ["10.1111/jns.12080_2", "25269728"]}, {"Citation": "Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS. Progress report on new antiepileptic drugs: A summary of the Twelfth Eilat Conference (EILAT XII). Epilepsy Res. 2015;111:85\u2013141. doi: 10.1016/j.eplepsyres.2015.01.001 .", "ArticleIdList": ["10.1016/j.eplepsyres.2015.01.001", "25769377"]}, {"Citation": "Hill TD, Cascio MG, Romano B, Duncan M, Pertwee RG, Williams CM, et al.\nCannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism. Br J Pharmacol. 2013;170(3):679\u201392. doi: 10.1111/bph.12321 ; PubMed Central PMCID: PMCPMC3792005.", "ArticleIdList": ["10.1111/bph.12321", "PMC3792005", "23902406"]}, {"Citation": "Hosking RD, Zajicek JP. Therapeutic potential of cannabis in pain medicine. Br J Anaesth. 2008;101(1):59\u201368. doi: 10.1093/bja/aen119 .", "ArticleIdList": ["10.1093/bja/aen119", "18515270"]}]}], "History": [{"Year": "2017", "Month": "7", "Day": "26"}, {"Year": "2017", "Month": "10", "Day": "9"}, {"Year": "2017", "Month": "10", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "10", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "12", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "10", "Day": "26"}], "PublicationStatus": "epublish", "ArticleIdList": ["29073181", "PMC5658086", "10.1371/journal.pone.0186864", "PONE-D-17-27908"]}}]}